Indonesia

Tuberculosis profile

| High TB burden | High HIV burden | High MDR-TB burden |

Population 2013
Estimates of TB burden * 2013
Mortality (excludes HIV+TB)
Mortality (HIV+TB only)
Prevalence (includes HIV+TB)
Incidence (includes HIV+TB)
Incidence (HIV+TB only)
Case detection, all forms (%)
Estimates of MDR-TB burden * 2013
% of TB cases with MDR-TB
MDR-TB cases among notified pulmonary
TB cases

250 million
Number (thousands)
64 (3693)
3.9 (2.26.2)
680 (3401 100)
460 (410520)
15 (8.720)
71 (6380)
New
1.9 (1.42.5)
5 700 (4 2007 500)

Rate
(per 100 000 population)
25 (1437)
1.6 (0.872.5)
272 (138450)
183 (164207)
5.8 (3.57.8)

Retreatment
12 (8.117)

Total new and relapse

Previously treated, excluding relapses
Total cases notified

325 582
1 521
327 103

Treatment success rate

New and relapse cases registered in 2012
Previously treated cases, excluding relapse, registered in 2012
HIV-positive TB cases, all types, registered in 2012
RR-/MDR-TB cases started on second-line treatment in 2011
XDR-TB cases started on second-line treatment in 2011
Laboratories 2013
Smear (per 100 000 population)
Culture (per 5 million population)
Drug susceptibility testing (per 5 million population)
Sites performing Xpert MTB/RIF
Is second-line drug susceptibility testing available?
Financing TB control 2014
National TB programme budget (US$ millions)
% Funded domestically
% Funded internationally
% Unfunded
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history

0
1990

1994

1998

2002

2006

2010

2006

2010

800

Relapse
6 406
1 558

400
0
1990

1994

1998

2002

Prevalence
(Rate per 100 000 population per year)
200

Among 325 582 new and relapse cases:

26 054 (8%) cases aged under 15 years; male:female ratio: 1.4

TB/HIV 2013
TB patients with known HIV status
HIV-positive TB patients
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)
HIV-positive TB patients on antiretroviral therapy (ART)
HIV-positive people screened for TB
HIV-positive people provided with IPT

40

(Rate per 100 000 population)

1 100 (7701 600)

New **
196 310
103 888
17 420

New
53 (<1%)

80

Mortality (excludes HIV+TB)

TB case notifications 2013

Pulmonary, bacteriologically confirmed
Pulmonary, clinically diagnosed
Extrapulmonary

Reported cases of RR-/MDR-TB 2013

Cases tested for RR-/MDR-TB
Laboratory-confirmed RR-/MDR-TB cases
Patients started on MDR-TB treatment

***
(Rate per 100 000 population per year)

100
Retreatment
3 740 (39%)

Number
7 631
1 599
477
332
22 190

Total **
3 838
912
809
(%)
(2)
(21)
(30)
(21)

0
1990

1994

2.2
0.4
0.2
23
Yes, in country

127
13%
30%
57%

2002

2006

Notified (new and relapse)

Incidence (HIV+TB only)

2010

Incidence

(Number of patients)
3000
2000
1000
0
2003

(%)
86
71
49
60
50

1998

2005

2007

2009

2011

HIV-positive TB patients
on CPT
on ART
Treatment success rate (%)
90
70
50
30
1995 1997 1999 2001 2003 2005 2007 2009 2011
New
Retreatment
New and relapse
Retreatment, excluding
relapse
HIV-positive
RR-/MDR-TB
XDR-TB
Total budget (US$ millions)
150
100
50
0
2010

__
__

2011

Funded domestically
Unfunded

Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
Generated: 2015-07-30

2012

__

2013

2014

Funded internationally

Data: www.who.int/tb/data